The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department

Overview of attention for article published in BMC Medicine, January 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

blogs: 1 blog
twitter: 4 X users

patent: 4 patents
facebook: 2 Facebook pages

Citations

dimensions_citation: 137 Dimensions

Readers on

mendeley: 178 Mendeley

Summary Blogs X Patents Facebook Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Method for predicting a treatment response to a CRHR1 antagonist and/or a V1B antagonist…

Grant US-10837062-B2

United States of America

Method for predicting a treatment response to a CRHR1 antagonist and/or a V1B antagonist…

Grant US-10190168-B2

United States of America

METHOD FOR PREDICTING A TREATMENT RESPONSE TO A V1B RECEPTOR ANTAGONIST IN A PATIENT WITH…

Application EP-3276010-A1

European Patent Office

V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL…

Application WO-2013186399-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.